Sydney Towle, 26, has documented her journey with a rare, aggressive bile duct cancer since she was diagnosed in 2023 ...
The City of Springfield is observing its first Cholangiocarcinoma Awareness Month this February, lighting local landmarks ...
February is Cholangiocarcinoma Awareness Month, a time to shine a light on this disease and the people it affects.
In October of 2005, my brother, Mark, was diagnosed with cholangiocarcinoma, a rare and aggressive cancer of the bile duct, at the age of 38. This set me on a path of relentless research and advocacy.
A new drug application (NDA) has been submitted to the FDA seeking approval of lirafugratinib (RLY-4008), a selective FGFR2 ...
The City of Springfield will mark February as Cholangiocarcinoma Awareness Month with a public event at City Hall and a ...
Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who have ...
Stacie C. Lindsey is being recognized for her patient advocacy, alignment of research efforts and collaboration among the cancer community. AstraZeneca and Scientific American Custom Media sponsor the ...
Upregulated WNT signalling is a key feature of cholangiocarcinoma, and targeting WNT pathways has therapeutic potential, according to new research published in The Journal of Clinical Investigation.
Cholangiocarcinoma arises from the bile ducts and is the most common primary malignancy of the biliary tree. Cholangiocarcinoma is classified according to its growth pattern: mass-forming, ...
Cholangiocarcinoma is a relatively rare adenocarcinoma of the bile ducts that is rapidly fatal unless it can be completely resected. In most cases, the tumor is too advanced for resection by the time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results